2026 Compounding Pharmacy – Key M&A Considerations for Sellers
Compounding pharmacy remains a sector that competes on innovation, clinical value, and service—not price. Businesses that compete primarily on price[...]
More
Market Reports
2025 Private Equity Update – Healthcare Services & Pharmacy
Other private equity investors might acquire a target to enhance their purchasing power. For example, in the case of a[...]
More
2024 Behavioral Health LTC Pharmacy Special Report
In my 2023 Market Outlook Report I wrote about how marginalized patient populations and economic inflation can impact pharmacy values.[...]
More
2023 Compounding Pharmacy M&A Market Update – How USP 800, Semaglutide And Competitive Forces Will Shape The Industry
This year is a dynamic and fast-paced one for compounding pharmacy M&A. Early in the year, unpredictability in the broader[...]
More
2023 LTC Pharmacy Market Update – How Inflation and Marginalized Patients Will Impact Values in The Coming Years
LTC Pharmacy underwent more disruption and change in just the past few years than the preceding decades. Revenue models morphed,[...]
More
Healthcare M&A Valuations Expected To Remain Strong In 2023 Despite Uncertainty
The healthcare services sector continues to attract attention from buyers across a broad range of backgrounds. While late 2021 and[...]
More
How Economic Uncertainty Will Impact Pharmacy Valuations in 2023
The healthcare services sector continues to attract attention from buyers across a broad range of backgrounds. While late 2021 and[...]
More
2022 Compounding Pharmacy Market Outlook
What’s driving the interest in compounding pharmacy? Disruption, growth and industry architecture. First, acquirers are aggressively seeking to establish boots[...]
More
2022 LTC Pharmacy Market Outlook Report
If you are reading this, you’re likely seeking an answer to the popular question: “How has the pandemic impacted the[...]
More
2021 Compounding Pharmacy Market Outlook
For much of the last decade, compounding pharmacies encountered headwinds in the M&A markets. A combination of high government scrutiny,[...]
More
